FZD4 and triple-negative breast carcinoma: We assessed GPCR expression in four human triple-negative breast cancer cell lines (BT-20, HS-578, MDA-MB-157, and MDA-MB-436) and a control cell line (MCF-10A, a breast epithelial cell line).